相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term Efficacy and Safety of Lamivudine, Entecavir, and Tenofovir for Treatment of Hepatitis B Virus-Related Cirrhosis
Seyfettin Koklu et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Low hepatitis B envelope antigen seroconversion rate in chronic hepatitis B patients on long-term entecavir 0.5 mg daily in routine clinical practice
Anne Liu et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2013)
Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis
Roeland Zoutendijk et al.
GUT (2013)
Efficacy of Entecavir Treatment for up to 5 Years in Nucleos(t)ide-Naive Chronic Hepatitis B Patients in Real Life
Jie Luo et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2013)
Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir
Chia-Chi Wang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Efficacy and safety of entecavir in clinical practice in treatment-naive Caucasian chronic hepatitis B patients
Maria Buti et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)
Long-term safety and tolerability of entecavir in patients with chronic hepatitis B in the rollover study ETV-901
Michael P. Manns et al.
EXPERT OPINION ON DRUG SAFETY (2012)
Effectiveness of Hepatitis B Treatment in Clinical Practice
Steven J. Scaglione et al.
GASTROENTEROLOGY (2012)
Long-term continuous entecavir therapy in nucleos(t)ide-naive chronic hepatitis B patients
Atsushi Ono et al.
JOURNAL OF HEPATOLOGY (2012)
First-line treatment of chronic hepatitis B with entecavir or tenofovir in 'real-life' settings: from clinical trials to clinical practice
S. Pol et al.
JOURNAL OF VIRAL HEPATITIS (2012)
Three Years of Continuous Entecavir Therapy in Treatment-Naive Chronic Hepatitis B Patients: VIRAL Suppression, Viral Resistance, and Clinical Safety
Man-Fung Yuen et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, and Entecavir in Patients with Decompensated Chronic Hepatitis B Liver Disease
Yun-Fan Liaw et al.
HEPATOLOGY (2011)
Efficacy and Safety of Entecavir Versus Adefovir in Chronic Hepatitis B Patients With Hepatic Decompensation: A Randomized, Open-Label Study
Yun-Fan Liaw et al.
HEPATOLOGY (2011)
Effectiveness of entecavir in chronic hepatitis B NUC-naive patients in routine clinical practice
E. Ridruejo et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2011)
Entecavir Treatment for up to 5 Years in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Severe Lactic Acidosis During Treatment of Chronic Hepatitis B with Entecavir in Patients with Impaired Liver Function
Christian M. Lange et al.
HEPATOLOGY (2009)
Long-Term Monitoring Shows Hepatitis B Virus Resistance to Entecavir in Nucleoside-Naive Patients Is Rare Through 5 Years of Therapy
Daniel J. Tenney et al.
HEPATOLOGY (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy
Daniel Shouval et al.
JOURNAL OF HEPATOLOGY (2009)
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
TT Chang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
CL Lai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Treating Individuals 1 - External validity of randomised controlled trials: To whom do the results of this trial apply?'
PM Rothwell
LANCET (2005)
Updated definitions of healthy ranges for serum alanine aminotransferase levels
D Prati et al.
ANNALS OF INTERNAL MEDICINE (2002)
分享论文
